CSII has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CSII has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cardiovascular Systems's YoY EBITDA Growth for the quarter that ended in Dec. 2022 was 15.76%.
Cardiovascular Systems's EBITDA per Share for the three months ended in Dec. 2022 was $-0.16.
The historical data trend for Cardiovascular Systems's YoY EBITDA Growth can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardiovascular Systems Annual Data | |||||||||||||||||||||
Trend | Jun13 | Jun14 | Jun15 | Jun16 | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | Jun22 | |||||||||||
YoY EBITDA Growth | Get a 7-Day Free Trial | 147.78 | -32.29 | -502.65 | 69.90 | -317.49 |
Cardiovascular Systems Quarterly Data | ||||||||||||||||||||
Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | |
YoY EBITDA Growth | Get a 7-Day Free Trial | -584.21 | -74.78 | -115.38 | -31.03 | 15.76 |
YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.
Cardiovascular Systems's YoY EBITDA Growth for the fiscal year that ended in Jun. 2022 is calculated as:
YoY EBITDA Growth (A: Jun. 2022 ) | |||||
= | (EBITDA per Share (A: Jun. 2022 ) | - | EBITDA per Share (A: Jun. 2021 )) | / | | EBITDA per Share (A: Jun. 2021 ) | |
= | (-0.764 | - | -0.183) | / | | -0.183 | |
= | -317.49 % |
Cardiovascular Systems's YoY EBITDA Growth for the quarter that ended in Dec. 2022 is calculated as:
YoY EBITDA Growth (Q: Dec. 2022 ) | |||||
= | (EBITDA per Share (Q: Dec. 2022 ) | - | EBITDA per Share (Q: Dec. 2021 )) | / | | EBITDA per Share (Q: Dec. 2021 )) | |
= | (-0.155 | - | -0.184) | / | | -0.184 | |
= | 15.76 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Cardiovascular Systems's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.
Jeffrey S. Points | officer: Chief Financial Officer | C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112 |
Scott R Ward | director | RAYMOND HOLDINGS, LLC, 6410 BALLANTINE CT., INVER GROVE HEIGHTS MN 55077 |
Erik Paulsen | director | C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112 |
Rhonda J. Robb | officer: Chief Operating Officer | C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112 |
Martha Goldberg Aronson | director | 40 WEST HIGHLAND PARK DRIVE NE, HUTCHINSON MN 55350 |
Sachin H. Jain | director | C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112 |
Alexander Rosenstein | officer: General Counsel & Corp. Secy | C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112 |
Sandra Sedo | officer: Chief Compliance Officer | C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112 |
Kelvin K. Womack | director | C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112 |
Stephen J. Rempe | officer: Chief Human Resources Officer | C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112 |
John M. Hastings | officer: VP Manufacturing & Operations | C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112 |
Stephen Stenbeck | director | C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112 |
Ryan Egeland | officer: VP of Medical Affairs | C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112 |
David Whitescarver | officer: VP of Corp. Dev. & IP | C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112 |
Laura Gillund | officer: Chief Talent Officer |
From GuruFocus
By Business Wire Business Wire • 03-09-2022
By sperokesalga sperokesalga • 03-30-2023
By sperokesalga sperokesalga • 02-09-2023
By PRNewswire PRNewswire • 02-16-2023
By PRNewswire PRNewswire • 02-22-2023
By PRNewswire PRNewswire • 03-02-2023
By Business Wire Business Wire • 10-17-2022
By Business Wire Business Wire • 03-22-2022
By Business Wire Business Wire • 01-11-2023
By sperokesalga sperokesalga • 02-19-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.